Serum soluble ST2: An effective prognostic biomarker for mortality in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation

Key Points

• Serum soluble ST2 significantly predicts mortality in COPD patients requiring invasive mechanical ventilation, underscoring its prognostic value.
• The study highlighted a correlation between elevated ST2 levels and increased mortality risk, emphasizing the need for close monitoring.
• This analysis utilized data from patients experiencing a severe acute exacerbation of chronic obstructive pulmonary disease needing ventilation support.
• The findings support the use of ST2 levels to guide treatment choices, but clinical validation in broader populations is necessary.